The Role of Wearables in Heart Failure

Abstract

Purpose of Review This review discusses how wearable devices-sensors externally applied to the body to measure a physiological signal-can be used in heart failure (HF) care. Recent Findings Most wearables are marketed to consumers and can measure movement, heart rate, and blood pressure; detect and monitor arrhythmia; and support exercise training and rehabilitation. Wearable devices targeted at healthcare professionals include ECG patch recorders and vests, patches, and textiles with in-built sensors for improved prognostication and the early detection of acute decompensation. Integrating data from wearables into clinical decision-making has been slow due to clinical inertia and concerns regarding data security and validity, lack of evidence of meaningful impact, interoperability, regulatory and reimbursement issues, and legal liability. Summary Although few studies have assessed how best to integrate wearable technologies into clinical practice, their use is rapidly expanding and may support improved decision-making by patients and healthcare professionals along the whole patient pathway.

A Blockchain-Enabled Framework for mHealth Systems

“…Analysis of these bio-potential signals and biomedical parameters allows earlier detection and prevention of cardiovascular diseases, and helps both medical experts and patients manage cardiovascular problems better. mHealth systems are used to help manage cardiopulmonary diseases such as hypertension, arrhythmia, coronary artery disease and heart failure, myocardial infarction, pulmonary hypertension, and chronic obstructive pulmonary disease [ 6 , 7 , 8 , 9 , 10 , 11 , 12 ]. In particular, the early detection of atrial fibrillation arrhythmia, most commonly, using mHealth systems can prevent strokes and reduce hospitalizations [ 13 , 14 , 15 ].…”

Diagnosis and Risk Prediction of Dilated Cardiomyopathy in the Era of Big Data and Genomics

“…Whether these innovative approaches can mitigate rehospitalisation (if acted upon) remains to be investigated. In addition, the benefit of wearables for arrhythmia detection or pre-clinical disease detection (e.g., by ECGs) in at-risk individuals needs to be evaluated in large prospective studies [ 112 ].…”

Tópicos Emergentes em Insuficiência Cardíaca: O Futuro na Insuficiência Cardíaca: Telemonitoramento, Wearables , Inteligência Artificial e Ensino na Era Pós-Pandemia

“…A redução na mortalidade geral pode variar de 19 a 31% com o TMOI ou TMIONI em pacientes com IC, 5,6 enquanto a redução na frequência de internação hospitalar por IC varia de 27 a 39%, principalmente em pacientes em classe funcional III/IV. [7][8][9] O TMOI com evidências mais convincentes na IC é o CardioMEMS, 7 um dispositivo implantado via percutânea na artéria pulmonar, que transmite os valores pressóricos centrais para um servidor seguro e orienta o ajuste nas doses de diuréticos e vasodilatadores.…”

“…gadget que se proponha a trazer estes benefícios, levando em consideração as principais barreiras para sua implementação, mas definitivamente os wearables chegaram para ficar. 8,9 Inteligência Artificial e Big Data na IC Sistemas computacionais capazes de realizar tarefas que originalmente exigiam atuação humana constituem a base da inteligência artificial (IA). Esses sistemas surgiram pela necessidade de interpretação de grande volume de dados (big data).…”